Russia Unveils Free mRNA Cancer Vaccine, Human Trials Set for 2025

Follow

( 0 Followers )

X

Follow

E-mail : *

Follow Unfollow

Russia has announced the launch of a personalized mRNA cancer vaccine, with human trials expected to begin between September and October 2025, according to reports from state agency TASS and the Economic Times.

The vaccine — initially designed to treat melanoma, a severe form of skin cancer — uses mRNA technology, the same scientific breakthrough that powered COVID-19 vaccines. Unlike traditional treatments, it creates tailored therapy for each patient by targeting the genetic makeup of their tumor. Russian authorities have also stated that once approved, it will be provided free of charge to patients in Russia.

President Vladimir Putin previously hinted at this milestone, saying the country was “close to creating cancer vaccines and immunomodulatory drugs of a new generation.”

However, Western health experts remain skeptical. Outlets like Newsweek note that Russia’s track record with medical breakthroughs — including the Sputnik V COVID-19 vaccine, which faced criticism for rushed approvals — raises questions about transparency and trial rigor. For now, little data has been shared on safety or long-term effectiveness, making it too early to fully assess the vaccine’s impact.

Trust in the project will hinge on the outcomes of clinical trials. If successful, it could mark a major leap in cancer treatment, not just for Russia but globally. If not, it risks adding to the list of overhyped medical claims.

For now, the world watches as Russia positions itself at the forefront of the race to transform how cancer is treated.